APOM and COVID-19: The novel, major finding of this work was the significant decrease of serum S1P level in COVID‐19 patients, which was significantly related to the decrease of erythrocytes, the major cellular source of circulating S1P, as well as of the two key S1P transporters apoM and albumin.